Filter
63
Filtered Results: 63
Text search:
Coalition
for
Epidemic
Preparedness
Innovations
(CEPI)
Featured
Recommendations
10
New Publications
10
Language
Document type
Studies & Reports
18
No document type
17
Strategic & Response Plan
11
Fact sheets
6
Guidelines
5
Manuals
3
Training Material
1
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
12
Syria
2
Brazil
2
Latin America and the Carribbean
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Liberia
1
Nigeria
1
Congo, Democratic Republic of
1
Bangladesh
1
Colombia
1
Bolivia
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western and Central Europe
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Countries
8
Key Resources
8
Public Health
5
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
COVID-19
33
Health Financing Toolbox
9
Rapid Response
4
Global Health Education
4
Ebola
2
AMR
2
Conflict
1
Refugee
1
TB
1
Caregiver
1
Planetary Health
1
Pharmacy
1
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to m...
As of December 2018, CEPI has secured more than USD $747million towards its USD $1billion funding target, with financial support provided by the Bill & Melinda Gates Foundation, the Wellcome Trust, the European Commission, and the governments of Aus...
the Principles for Dose-Sharing provide a framework for higher-income economies to make additional volumes secured via bilateral deals available through the Facility primarily to AMC participants, o...
Board of Directors Report 2016-2017 of the Coalition for Epidemic Preparedness ... (CEPI) outlining financial information about CEPI regarding investors and accounts.
COVAX Initiative
recommended
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator
The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
COVAX is co-led by Gavi, the ... for Epidemic Preparedness Innovations (CEPI) and WHO. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.
Leading disease outbreak experts have come together to show gamers everywhere how to spot and stop a pandemic. The popular simulation Plague Inc: The Cure not only transports players into a global public health outbreak similar to the COVID-19 pandemic, but a new feature also provides expert comment...
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, ...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up in...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID...
In Control. A Practical Handbook for Professionals Working in Health Emergencies Internationally
recommended
In Control imparts knowledge, provokes reflection and triggers curiosity. The first half of the book provides an overview of the organisations, principles, frameworks and themes that every professional deploying to health emergencies should be aware of. The second half of the book provides practical...
In Control: A Practical Handbook for Professionals Working in Health Emergencies Internationally RKI
The greatest risk to persons engaging in international medical emergency response is poor preparation.
The In Control handbook hopes to provide a remedy.
At the time of writing, we are living through the Coronavirus (COVID-19) pandemic, a health emergency that disregards physical borders, brin...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collectiv...
This 10th edition of the Institute for Health Metrics and Evaluation’s annual Financing Global Health report provides the most up-to-date estimates of development assistance for health, domestic s...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an an...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the chan...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Acceler...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response r...
